Previous studies have reported that ERβ is expressed greater in normal colon tissues than pathologic tissues [51], and that the increased ratio of ERα and β due to altered expression of ER subtypes is found in patients with CRC [40], supporting the role of ERβ as a relevant prognostic biomarker of tumor progression [52]. The gene discussed is ESR1; the disease is neoplasm.